Leukemia-Fighting Drug

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

HEALTHWATCH - A new era in medicine as a FDA panel recommends approval for gene therapy in the fight against leukemia.

It’s the first treatment that would genetically alter a patient’s own cells to fight leukemia. It transforms the patient into what scientists call a living drug. University of Pennsylvania researchers developed the individualized treatment in which cells would be removed and shipped to a drug company, processed, and then sent back. Analysts predict individual costs could reach $300,000, but the treatment has been successful in scores of patients.

Segment Sponsored by: Mercy Health System